Drugs / VAI-VP705
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00379938 | Aug 2006 → Oct 2008 | Parvoviridae infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VAI-VP705 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00379938 ↗ |
| Modality | Vaccine | “a recombinant human parvovirus B-19 vaccine (VAI-VP705)” NCT00379938 ↗ |